147 related articles for article (PubMed ID: 35839956)
21. Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta
Shubbar MH; Penny JI
Eur J Pharmacol; 2020 May; 874():173009. PubMed ID: 32061744
[TBL] [Abstract][Full Text] [Related]
22. Multi-target ABC transporter modulators: what next and where to go?
Stefan SM
Future Med Chem; 2019 Sep; 11(18):2353-2358. PubMed ID: 31516029
[No Abstract] [Full Text] [Related]
23. Karanjin interferes with ABCB1, ABCC1, and ABCG2.
Michaelis M; Rothweiler F; Nerreter T; Sharifi M; Ghafourian T; Cinatl J
J Pharm Pharm Sci; 2014; 17(1):92-105. PubMed ID: 24735762
[TBL] [Abstract][Full Text] [Related]
24. ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics.
Jha NK; Kar R; Niranjan R
Curr Top Med Chem; 2019; 19(10):795-811. PubMed ID: 30977450
[TBL] [Abstract][Full Text] [Related]
25. C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.
Namasivayam V; Silbermann K; Wiese M; Pahnke J; Stefan SM
J Med Chem; 2021 Mar; 64(6):3350-3366. PubMed ID: 33724808
[TBL] [Abstract][Full Text] [Related]
26. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
27. Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression.
Michaelis M; Rothweiler F; Nerreter T; van Rikxoort M; Zehner R; Dirks WG; Wiese M; Cinatl J
BMC Res Notes; 2014 Oct; 7():710. PubMed ID: 25300205
[TBL] [Abstract][Full Text] [Related]
28. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
[TBL] [Abstract][Full Text] [Related]
29. A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors.
Stefan SM; Jansson PJ; Pahnke J; Namasivayam V
Sci Data; 2022 Jul; 9(1):446. PubMed ID: 35882865
[TBL] [Abstract][Full Text] [Related]
30. Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development.
Moinul M; Amin SA; Jha T; Gayen S
Eur J Med Chem; 2022 Nov; 241():114628. PubMed ID: 35944339
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle.
Haslam IS; El-Chami C; Faruqi H; Shahmalak A; O'Neill CA; Paus R
Br J Dermatol; 2015 Jun; 172(6):1562-1572. PubMed ID: 25418064
[TBL] [Abstract][Full Text] [Related]
32. Structural feature-driven pattern analysis for multitarget modulator landscapes.
Namasivayam V; Stefan K; Silbermann K; Pahnke J; Wiese M; Stefan SM
Bioinformatics; 2022 Feb; 38(5):1385-1392. PubMed ID: 34888617
[TBL] [Abstract][Full Text] [Related]
33. Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1.
Wu CP; Hsiao SH; Sim HM; Luo SY; Tuo WC; Cheng HW; Li YQ; Huang YH; Ambudkar SV
Biochem Pharmacol; 2013 Oct; 86(7):904-13. PubMed ID: 23962445
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.
Pahnke J; Langer O; Krohn M
Neurobiol Dis; 2014 Dec; 72 Pt A():54-60. PubMed ID: 24746857
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.
Dohse M; Scharenberg C; Shukla S; Robey RW; Volkmann T; Deeken JF; Brendel C; Ambudkar SV; Neubauer A; Bates SE
Drug Metab Dispos; 2010 Aug; 38(8):1371-80. PubMed ID: 20423956
[TBL] [Abstract][Full Text] [Related]
36. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
37. Using a qPCR device to screen for modulators of ABC transporter activity: A step-by-step protocol.
Möhle L; Schwarzová B; Krohn M; Stefan SM; Pahnke J
J Pharmacol Toxicol Methods; 2020; 104():106882. PubMed ID: 32474136
[TBL] [Abstract][Full Text] [Related]
38. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
Shen B; Li D; Dong P; Gao S
Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
[TBL] [Abstract][Full Text] [Related]
39. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
40. Chorioamnionitis Induces a Specific Signature of Placental ABC Transporters Associated with an Increase of miR-331-5p in the Human Preterm Placenta.
do Imperio GE; Bloise E; Javam M; Lye P; Constantinof A; Dunk C; Dos Reis FM; Lye SJ; Gibb W; Ortiga-Carvalho TM; Matthews SG
Cell Physiol Biochem; 2018; 45(2):591-604. PubMed ID: 29402780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]